Digestive & Intestinal Remedies (Pharmacies) - Sweden

  • Sweden
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$49.68m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.43%, resulting in a market volume of US$50.75m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$4.66 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Sweden is experiencing steady growth due to changing customer preferences, emerging trends in the market, and local special circumstances.

Customer preferences:
Customers in Sweden are increasingly seeking natural and organic remedies for digestive and intestinal issues. They are more conscious about the ingredients used in these remedies and prefer products that are free from artificial additives and preservatives. This shift towards natural remedies is driven by a growing awareness of the potential side effects of traditional medications and a desire for more holistic approaches to healthcare.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Sweden is the rising demand for probiotics. Probiotics are beneficial bacteria that promote a healthy digestive system. They are commonly found in fermented foods and supplements. The popularity of probiotics can be attributed to the growing interest in gut health and its impact on overall well-being. Consumers are increasingly turning to probiotic supplements to improve digestion and boost their immune system. Another trend in the market is the increasing availability of over-the-counter (OTC) digestive remedies. Previously, many digestive and intestinal remedies required a prescription. However, there has been a shift towards making these products more accessible to consumers without the need for a doctor's visit. This has led to an increase in the variety of OTC options available in pharmacies, making it easier for customers to find the right product for their needs.

Local special circumstances:
Sweden has a high rate of lactose intolerance, with a significant portion of the population unable to digest lactose, the sugar found in milk and dairy products. This has led to a greater demand for lactose-free digestive remedies in the market. Pharmacies in Sweden often stock a wide range of lactose-free products to cater to the needs of lactose-intolerant customers.

Underlying macroeconomic factors:
The growing Digestive & Intestinal Remedies market in Sweden is also influenced by underlying macroeconomic factors. The country has a high standard of living and a well-developed healthcare system, which allows consumers to prioritize their health and well-being. Additionally, Sweden has a strong focus on preventive healthcare, with a high level of awareness about the importance of maintaining a healthy lifestyle. This has contributed to the increasing demand for digestive and intestinal remedies as consumers take proactive steps to manage their digestive health. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Sweden is driven by changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for natural and organic remedies, the popularity of probiotics, the availability of OTC options, the prevalence of lactose intolerance, and the country's focus on preventive healthcare all contribute to the growth of this market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)